Latest coronavirus news

  • National consortium to study the threats of new SARS-CoV-2 variants 15 January 2021 A new national research project to study the effects of emerging mutations in SARS-CoV-2 is launched today [15 Jan]. The £2.5 million UK Research and Innovation (UKRI)-funded ‘G2P-UK’ National Virology Consortium will study how mutations in the virus affect key outcomes such as how transmissible it is, the severity of COVID-19 it causes, and the effectiveness of vaccines and treatments.
  • Global experts urge everyone to talk about COVID-19 vaccines responsibly 7 January 2021 A team of renowned scientific experts has joined forces from across the world to help fight the spread of misinformation about the COVID-19 vaccines, which hold the key to beating the deadly pandemic and releasing countries from debilitating lockdown restrictions.
  • Vaccines must prevent infection, disease progression and transmission – in every country - to truly bring COVID-19 under control 15 December 2020 An editorial co-authored by a member of the UK's influential SAGE committee that advises the UK Government on COVID-19, and published in Anaesthesia (a journal of the Association of Anaesthetists) says that in order for the global COVID-19 vaccination program to be successful, the available vaccines must be able to do all three of: prevent infection becoming established in an individual, prevent disease progression and prevent onward transmission.
  • Majority of University of Bristol students are complying with government COVID-19 guidelines 15 December 2020 The majority of University of Bristol students are complying with government COVID-19 guidelines and are self-isolating when receiving a positive test, indicates a study that has investigated student social contact patterns and behaviours. The research led by scientists at the University of Bristol is published on the pre-print server medRxiv.
  • Increased risk of domestic violence over Christmas 10 December 2020 Domestic violence and health experts from the University of Bristol are urging men in Bristol, South Gloucestershire, North Somerset, Somerset, Wiltshire and Gwent (South Wales) to get in touch if they are worried about being abusive or controlling in their relationships with women.
  • Preschoolers’ eating, activity and sleep behaviours were impacted during first COVID-19 lockdown, study suggests 10 December 2020 Preschool children’s eating, activity, and sleep routines were disrupted during the spring COVID-19 lockdown, which may be detrimental to child health and development a study suggests. Parents of children (aged three- to five-year-old) due to start school in September 2020 shared their children’s experiences of the spring lockdown with academics from the Universities of Bristol, Birmingham and Glasgow.
  • Analysis finds four repurposed antiviral drugs have little or no effect on patients hospitalised for COVID-19 4 December 2020 Repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon - to treat COVID-19 appear to have little or no effect on patients hospitalised for the disease, in terms of overall mortality, initiation of ventilation and duration of hospital stay. The interim findings from the WHO Solidarity trial, published in the New England Journal of Medicine (NEJM), followed 11,266 adults at 405 hospitals in 30 countries.
  • The COVID-19 pandemic: in a world of fake news, why science matters 2 December 2020 The COVID-19 pandemic raises important questions about the role of life sciences in society and if the voices of scientists are now less audible or less important, is this a problem and how can this be addressed? This question will be one of many tackled by a panel, including Nobel Prize-winning biologist, Sir Paul Nurse and Bristol Mayor, Marvin Rees, for a live online event to celebrate the launch of the University of Bristol's Faculty of Life Sciences.
  • New study to investigate COVID-19 and misinformation 1 December 2020 Researchers at the University of Bristol and King's College London are leading a major new study to investigate COVID-19 perceptions and misperceptions, lockdown compliance and vaccine hesitancy.
  • Exceptional challenges of bereavement during the pandemic highlighted in interim findings 27 November 2020 Interim findings of a survey of people bereaved in the UK since March, led by researchers from the univerities of Bristol and Cardiff and the Marie Curie Palliative Care Research Centre, show the difficulties and distress experienced by those who have lost a loved one, both prior to the death and in their grief.
  • World's first research programme to identify scarring gene launched 26 November 2020 A world-leading £1.5 million research programme that aims to achieve scar free healing within a generation has been launched today [26 November] by The Scar Free Foundation, the only medical research charity which focuses solely on scarring. The five-year research study led by the University of Bristol will identify the gene(s) that causes scarring and inform future treatments.
  • Spread Germ Defence, not the virus! 25 November 2020 With Covid-19 infections still high and people preparing for Christmas gatherings, it is vitally important to try to reduce the spread of infection in people's homes as this is where infections are now most likely to be transmitted. Research suggests people who follow the advice from Germ Defence are less likely to catch flu or other viruses and less likely to pass it on to members of their household.
  • Young people's anxiety levels doubled during first COVID-19 lockdown, says study 24 November 2020 The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol. The study, using Bristol’s Children of the 90s questionnaire data, showed that young people (27-29 years) reported higher levels of anxiety during the early phases of the pandemic in the first national lockdown and this was higher than their parents.
  • Rapid point-of-care testing during and after COVID-19 – how widely should it be used? 17 November 2020 Even before the COVID-19 pandemic, the point-of-care testing industry was investing millions of pounds to develop rapid tests to tell us the cause of respiratory infections. The pandemic has accelerated this process. In an editorial published in the British Journal of General Practice today [17 November], researchers from the University of Bristol’s Centre for Academic Primary Care ask if we know enough about these tests to merit their widespread use in primary care.
  • Accuracy of rapid covid test may be lower than previously suggested 12 November 2020 The accuracy of a rapid finger-prick antibody test for SARS-CoV-2, the virus responsible for Covid-19 infection, may be considerably lower than previously suggested, finds a study led by scientists from Public Health England and the Universities of Bristol, Cambridge and Warwick published in The BMJ.
  • Interactive virtual reality emerges as a new tool for drug design against COVID-19 12 November 2020 Bristol scientists have demonstrated a new virtual reality [VR] technique which should help in developing drugs against the SARS-CoV-2 virus – and enable researchers to share models and collaborate in new ways. The innovative tool, created by University of Bristol researchers, and published in the Journal of Chemical Information and Modeling, will help scientists around the world identify anti-viral drug leads more rapidly.
  • #8Investments to enable everyone, everywhere, to be physically active 10 November 2020 Researchers from the University of Bristol and NIHR ARC West have contributed to the International Society for Physical Activity and Health (ISPAH) ‘Eight Investments That Work for Physical Activity‘, released today [10 November].
  • Bristol COVID-19 experts to answer your questions 4 November 2020 COVID-19 has had an enormous impact on nearly every aspect of our everyday lives. In response, researchers from the University of Bristol are working together and with partners around the world to understand the virus, develop a vaccine and help bring an end to the pandemic.
  • What’s the STORY of infectious diseases in the UK? 26 October 2020 A study looking at how children's immune systems respond to COVID-19, and to vaccines for other infectious diseases, is asking children under the age of 20 who live in the Bristol area to consider taking part. The research project is being run by the Bristol Children’s Vaccine Centre (BCVC) at Bristol Medical School, and the Oxford Vaccine Group which is part of the University of Oxford.
  • Oxford COVID-19 vaccine follows its programmed genetic instructions, independent analysis finds 22 October 2020 The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) now undergoing Phase III clinical trials, has already undergone rigorous testing to ensure the highest standards of quality and safety. Now a team at Bristol University has used recently developed techniques to further validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford team. This novel analysis provides even greater clarity and detail about how the vaccine successfully provokes a strong immune response.
Years iterator
Edit this page